Revised SPCs: Keppra (levetiracetam) products

Source:
electronic Medicines Compendium - eMC
Publisher:
electronic Medicines compendium
Publication date:
30 October 2019

Abstract

SPCs updated to warn that levetiracetam may cause psychotic symptoms and behavioural abnormalities including irritability and aggressiveness. If such behaviours are noticed, treatment adaptation or gradual discontinuation should be considered.